Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment
Molecular Oncology · 2025
DOI: 10.1002/1878-0261.70055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Eline Biscop und 10 weiteren Autor:innen. Beteiligte Einrichtung: PLASMANT, Department of Chemistry, University of Antwerp, Belgium. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Plasma Gases, Melanoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Despite the promising results of non‐thermal plasma (NTP) devices for cancer therapy, the potential adverse effects of NTP irradiation have remained unexplored, including the effects on epithelial‐mesenchymal transition (EMT) and subsequent cancer metastasis. In this study, we investigate NTP‐induced EMT initiation and progression. A microsecond‐pulsed dielectric barrier discharge plasma device was used for NTP treatment, and chicken chorioallantoic membrane (CAM) and spheroids were used as 3D tumor models. NTP treatment reduced tumor volume in the CAM model, but a shift towards a mesenchymal‐like phenotype was also measured in melanoma tumors via analysis of the six EMT biomarkers, though changes in cancer cell migration to other organs were not significant. In the spheroid model, molecular analysis also indicated an EMT response following NTP treatment, and enhanced cell migration was measured in one cell line. EMT induction with NTP was dose‐dependent and transient; high NTP treatments caused significant EMT response and enhanced migration, but low NTP doses did not. Our findings highlight the important role of NTP parameters for cancer treatment and consequential EMT responses. The insights obtained here further build the foundation for clinical optimization, harnessing the cancer‐killing potential of NTP while safeguarding against undesirable EMT‐related outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PLASMANT, Department of Chemistry, University of Antwerp, Belgium.
- Center for Oncological Research - Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Belgium.
- Industrial Vision Lab, Department of Applied Engineering, University of Antwerp, Belgium.
- Cell Death Signaling, Epigenetics Lab - Integrated Personalized & Precision Oncology Network (IPPON University of Antwerp), Belgium.
ORCID-Profile: Eline Biscop, Abraham Lin
Förderung
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Biscop, E., De La Hoz, E. C., Verswyvel, H., De Backer, J., Lau, H. W., Privat-Maldonado, A., Vanden Berghe, W., Vanlanduit, S., Smits, E., Bogaerts, A., & Lin, A. (2025). Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment. Molecular Oncology. https://doi.org/10.1002/1878-0261.70055
Vancouver
Biscop E, De La Hoz EC, Verswyvel H, De Backer J, Lau HW, Privat-Maldonado A, et al. Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment. Molecular Oncology. 2025. doi:10.1002/1878-0261.70055
BibTeX
@article{Biscop2025,
author = {Biscop, Eline and De La Hoz, Edgar Cardenas and Verswyvel, Hanne and De Backer, Joey and Lau, Ho Wa and Privat-Maldonado, Angela and Vanden Berghe, Wim and Vanlanduit, Steve and Smits, Evelien and Bogaerts, Annemie and Lin, Abraham},
title = {Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment},
journal = {Molecular Oncology},
year = {2025},
doi = {10.1002/1878-0261.70055}
}
EUVIMED